NASDAQ:LPTX - Leap Therapeutics, Inc.
$1.62
 $-0.02
-1.22%
4:00PM EDT
2019-04-18
Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company engages in acquiring and developing therapeutics in cancer biology. Leap's programs are monoclonal antibodies that target key cellular pathways that enable cancer to grow and spread and specific mechanisms that activate the body's immune system to identify and attack cancer. The Company's lead product candidates for use in clinical trials include TRX518 and DKN-01. DKN-01 is a monoclonal antibody targeting Dickkopf-related protein 1 (DKK1). DKK1 serves as the inhibitors of the canonical Wnt signaling pathway and modulates the non-canonical Wnt signaling pathways. When DKN-01 binds to DKK1, Wnt signaling pathways and the tumor microenvironment are altered, and an anti-tumor effect can be generated. The Company is testing DKN-01 in ongoing clinical trials in patients with esophageal cancer in combination with paclitaxel and in patients with cholangiocarcinoma in combination with gemcitabine and cisplatin. The Company has studied DKN-01 as a monotherapy in patients with non-small cell lung cancer (NSCLC). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  LPTX     avg for
industry  
  avg for
sector  
42 stocks weight:  1. 00   199. 07   233. 87  
42 stocks rank:  3. 29 K 1. 43 K 1. 06 K
# analyst opinions:  3. 00   14. 48   14. 09  

quick ratio:  2. 65   5. 29   1. 92  
current ratio:  2. 69   5. 64   2. 40  

target price low:  2. 55   84. 50   115. 74  
target price avg:  2. 76   110. 73   137. 39  
target price high:  3. 18   136. 41   157. 80  
1-yr high:  9. 44   114. 11   138. 85  
last close:  1. 62   87. 56   116. 78  
50-day avg:  1. 77   95. 43   123. 53  
200-day avg:  4. 44   94. 13   121. 20  
1-yr low:  1. 39   72. 67   98. 41  
volume:  989. 81 K 2. 43 M 4. 85 M
50-day avg volume:  1. 33 M 2. 72 M 4. 97 M
200-day avg volume:  414. 96 K 2. 90 M 4. 58 M

1-day return:  -1. 22 % -0. 40 % 0. 07 %
this week return:  -5. 81 % -5. 72 % -4. 11 %
12-wk return:  -44. 90 % 1. 78 % -0. 04 %
52-wk return:  -75. 70 % 10. 81 % 14. 09 %

enterprise value (EV):  26. 23 M 51. 19 B 117. 96 B
market cap:  36. 06 M 43. 00 B 104. 52 B
EBITDA:  -29. 95 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -0. 88   4. 34   13. 27  
total debt:  0. 00   12. 22 B 16. 66 B
net income (common):  -23. 14 M 2. 20 B 4. 21 B

shares outstanding:  22. 26 M 570. 91 M 1. 24 B
shares:  12. 44 M 571. 02 M 1. 23 B
shares short:  870. 50 K 9. 93 M 16. 79 M
shares short prior month:  403. 47 K 9. 96 M 16. 58 M
short ratio:  0. 65   5. 31   3. 30  
short % of float:  20. 06 % 5. 81 % 2. 61 %
total cash/share:  0. 73   11. 13   9. 30  
total cash:  16. 28 M 6. 70 B 7. 10 B
free cash flow:  -13. 99 M 3. 58 B 4. 74 B
operating cash flow:  -26. 03 M 4. 14 B 6. 32 B

book value:  0. 62   12. 76   26. 84  
price/book:  2. 60   3. 08   -1. 74  
operating margins:  0. 00 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  0. 00 % 37. 02 % 55. 68 %

1-yr max volatility:  -23. 08 % --- ---
1-yr mean volatility:  -0. 47 % 0. 03 % 0. 04 %

1-yr EPS:  -2. 11   2. 39   4. 08  
forward EPS:  -1. 38   3. 97   7. 14  
P/E:  -0. 77   13. 59   22. 83  
forward P/E:  -1. 25   -20. 05   14. 49  
PE/G:  0. 02   -1. 46   1. 68  
growth:  -42. 13 % 126. 81 % 29. 29 %
earnings high:  -0. 37   1. 02   1. 63  
earnings avg:  -0. 39   0. 76   1. 51  
earnings low:  -0. 42   0. 47   1. 39  
revenue high:  -0. 00   2. 68 B 10. 71 B
revenue avg:  -0. 00   2. 59 B 10. 49 B
revenue low:  -0. 00   2. 49 B 10. 25 B
return on assets:  -77. 89 % -2. 80 % 5. 29 %
return on equity:  -228. 05 % -18. 52 % 7. 38 %

beta (1yr vs S&P500):  0. 78   1. 24   0. 93  
sharpe (1yr):  -1. 35   0. 29   0. 60  

held % insiders:  13. 26 % 6. 38 % 3. 38 %
held % institutions:  40. 63 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : LPTX
.        + 0 =             0 :: INITIAL WEIGHT
.   + 32.704 =        32.704 :: spline projection addition
.    x 1.432 =        46.834 :: industry recommendation factor
.    x 0.992 =        46.469 :: return on assets factor
.    x 0.977 =        45.409 :: return on equity factor
.    x 2.476 =       112.441 :: current ratio factor
.    x 1.267 =       142.433 :: quick ratio factor
.    x 1.641 =       233.703 :: short ratio factor
.    x 2.026 =       473.474 :: price-to-book factor
.    x 2.165 =      1024.837 :: P/E weight
.    x 2.209 =      2263.823 :: PE/G factor
.    x 1.553 =      3515.771 :: beta factor
.    x 0.549 =      1928.746 :: sharpe factor
.    x 1.818 =       3506.08 :: target low factor
.     x 1.28 =      4486.354 :: target mean factor
.    x 1.098 =      4927.039 :: target high factor
.    x 1.312 =      6462.543 :: industry 2-weeks return factor
.    x 0.896 =      5789.765 :: "drift" penalty 1 days ago
.    x 0.888 =      5141.217 :: "drift" penalty 4 days ago
.    x 0.921 =      4734.043 :: overall "drift" factor
.    x 0.999 =      4729.375 :: largest single-day jump factor
.    x 0.064 =       303.944 :: low price factor
.      x 1.0 =       303.895 :: factor hist industry gain for week 15
.   cubeRoot =         6.723 :: reduced to standardize
.   - 28.042 =         0.998 :: add/subtract for performance
.                      0.998 :: FINAL WEIGHT for NASDAQ:LPTX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org